SEC Filing Update: #TNGX Tango Therapeutics, Inc. : $25.49

Sector: Healthcare | YTD: 🔼+ 185.12% The SEC disclosed Today (14-AUG-2026) that GOLDMAN SACHS GROUP INC has INCREASED #TNGX Shares by 91.92% 🟢 FARALLON CAPITAL MANAGEMENT LLC also reported an increase in its holdings on the same day. * Previous Holdings: 5.08M Shares * Current Holdings: 9.74M Shares * Increase+4.67M * Increased(%)+91.92% * Ownership: 6.0% * Estimated Investment Value: $127.15M https://www.thinksabio.com/reports/isr/TNGX Institutional ownership in #TNGX has been steadily rising over the past 12 quarters in Shares: Q4 2023: 93.64M Q1 2024: 98.40M Q2 2024: 98.60M Q3 2024: 101.47M Q4 2024: 106.44M Q1 2025: 107.29M Q2 2025: 127.26M Q3 2025: 139.98M Q4 2025: 172.39M Q1 2026: 180.26M The quarterly average prices of #TNGX: Q2 2025: $2.47 Q3 2025: $6.77 Q4 2025: $8.62 Q1 2026: $13.92 📌 Institutional activity in the last 30 days for #TNGX: • FARALLON CAPITAL MANAGEMENT LLC – Increased holdings by 7,172,776 shares (14-AUG-2026)